Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Contrast Media Market size was valued at US$ 6,536.1 million in 2023 and is projected to grow at a CAGR of 6.8% from 2024 to 2030. It is utilized in imaging techniques to enhance the difference between body tissues in images. The demand for contrast media is rising due to the need to meet the requirements of these advanced imaging modalities. As medical professionals and researchers strive for more detailed and accurate imaging, the demand for contrast media with specific properties, such as higher iodine concentrations, increases. Furthermore, in addition to the technological advancements in imaging modalities, innovations in imaging equipment, such as digital X-ray systems, also contribute to the demand for contrast media. These advancements enable healthcare providers to capture high-quality images with greater clarity and precision. As a result, the use of digital X-ray systems and other advanced imaging equipment has grown, further fueling the demand for contrast media.
Advancements in imaging technologies are driving a surge in demand for specialized contrast media. This demand presents a clear opportunity for further innovation and refinement in the contrast media industry, catering to the evolving requirements of modern diagnostic imaging. With the augmented prevalence and the rise in the number of cancer cases in both developing and developed economies of the world, it is essential to provide techniques that can aid patients get a diagnosis at the earlier stages. Moreover, the stipulation for diagnostics imaging is at an unsurpassed high, with several types of chronic diseases prevalent globally. For instance, as per the report stated by the Medicare Payment Advisory Commission (MedPAC) to the Center for Medicare and Medicaid Services (CMS), the upsurge in the volume of imaging amenities per medicare beneficiary is the utmost among all other services provided by doctors.
However, the challenges associated with this contrast media are patients may porn to adverse reactions such as allergic diseases, asthma, anxiety, skin redness, skin swelling, and dizziness. However, the key opportunities associated with the rising demand for voiding cystourethrography, intravenous urography, and hysterosalpingogram. Geographical expansion by the market players and government incentives for R&D activities create opportunities in the market.
Study Period
2024-2030Base Year
2023CAGR
6.8%Largest Market
Asia-PacificFastest Growing Market
North America
The increasing demand for contrast CTs, angiography, venography developed, and emerging countries is a key factor in the surge of the market over the forecast years. The key factors for the development of the contrast media market contain the rise in the incidences of chronic diseases, increasing demand for image-guided procedures and diagnostics, and an enormous number of approvals for contrast agents. Image-guided processes can help determine if a cancer is malignant or benign. The adult peoples pose a greater danger of chronic conditions with multiple comorbidities. The national Council on Aging report advocates that approximately 82% of people aged 65 and above suffer from at least one chronic condition, with almost 70% of medicare beneficiaries suffering from more than two chronic conditions, and nearly 78.32 million folks in the US are anticipated to be aged 62 and above by 2035.
For instance, as per the report stated by the American Heart Association, the incidence of heart failure is increasing in the US and it is one of the primary causes of death in the economies. In 2021, approximately 665,000 folks died owing to cardiovascular diseases in the US by 2030, the number of patients with heart diseases is predicted to rise by 47%.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 6,536.1 million |
Market CAGR |
6.8% |
By Product Type |
|
By Technology |
|
By Region |
|
Download Free Sample Report
The global contrast media market size was valued at US$ 6,536.1 million in 2023 and is projected to grow at a CAGR of 6.8% from 2024 to 2030.
Jodas Expoim Pvt. Ltd., GE HealthCare, Unijules Life Sciences Ltd., JB Pharma, Bracco, Lantheus, Sanochemia Pharmazeutika GmbH, TAEJOON Pharmaceutical Co., Ltd., Guerbet, Bayer AG, Spago Nanomedical AB, M. Biotech Limited, Fuji Pharma Co., Ltd., Trivitron Healthcare, Subhra Pharma, Beijing Beilu Pharmaceuticals Co. Ltd., and Jiangsu Hengrui Pharmaceutical Co., Ltd.,
The Contrast Media Market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
1.Executive Summary |
2.Global Contrast Media Market Introduction |
2.1.Global Contrast Media Market - Taxonomy |
2.2.Global Contrast Media Market - Definitions |
2.2.1.Type |
2.2.2.Application |
2.2.3.Region |
3.Global Contrast Media Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Contrast Media Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Contrast Media Market By Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Iohexol |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Iopamidol |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Iodixanol |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Iopromide |
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. Ioversol |
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
5.6. Iomeprol |
5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.6.3. Market Opportunity Analysis |
5.7. Gadoteric Acid |
5.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.7.3. Market Opportunity Analysis |
5.8. Gadobutrol |
5.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.8.3. Market Opportunity Analysis |
5.9. Gadoxetic Acid |
5.9.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.9.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.9.3. Market Opportunity Analysis |
5.10. Definity |
5.10.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.10.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.10.3. Market Opportunity Analysis |
5.11. Optison |
5.11.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.11.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.11.3. Market Opportunity Analysis |
5.12. SonoVue/Lumason |
5.12.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.12.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.12.3. Market Opportunity Analysis |
6.Global Contrast Media Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. X-Ray/CT |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. MRI |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Ultrasound |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
7.Global Contrast Media Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. North America |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Europe |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Asia Pacific (APAC) |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Middle East and Africa (MEA) |
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Latin America |
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
8.North America Contrast Media Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.1.1.Iohexol |
8.1.2.Iopamidol |
8.1.3.Iodixanol |
8.1.4.Iopromide |
8.1.5.Ioversol |
8.1.6.Iomeprol |
8.1.7.Gadoteric Acid |
8.1.8.Gadobutrol |
8.1.9.Gadoxetic Acid |
8.1.10.Definity |
8.1.11.Optison |
8.1.12.SonoVue/Lumason |
8.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.2.1.X-Ray/CT |
8.2.2.MRI |
8.2.3.Ultrasound |
8.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.3.1.United States of America (USA) |
8.3.2.Canada |
9.Europe Contrast Media Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Iohexol |
9.1.2.Iopamidol |
9.1.3.Iodixanol |
9.1.4.Iopromide |
9.1.5.Ioversol |
9.1.6.Iomeprol |
9.1.7.Gadoteric Acid |
9.1.8.Gadobutrol |
9.1.9.Gadoxetic Acid |
9.1.10.Definity |
9.1.11.Optison |
9.1.12.SonoVue/Lumason |
9.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.X-Ray/CT |
9.2.2.MRI |
9.2.3.Ultrasound |
9.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Germany |
9.3.2.France |
9.3.3.Italy |
9.3.4.United Kingdom (UK) |
9.3.5.Spain |
10.Asia Pacific (APAC) Contrast Media Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Iohexol |
10.1.2.Iopamidol |
10.1.3.Iodixanol |
10.1.4.Iopromide |
10.1.5.Ioversol |
10.1.6.Iomeprol |
10.1.7.Gadoteric Acid |
10.1.8.Gadobutrol |
10.1.9.Gadoxetic Acid |
10.1.10.Definity |
10.1.11.Optison |
10.1.12.SonoVue/Lumason |
10.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.X-Ray/CT |
10.2.2.MRI |
10.2.3.Ultrasound |
10.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.China |
10.3.2.India |
10.3.3.Australia and New Zealand (ANZ) |
10.3.4.Japan |
10.3.5.Rest of APAC |
11.Middle East and Africa (MEA) Contrast Media Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Iohexol |
11.1.2.Iopamidol |
11.1.3.Iodixanol |
11.1.4.Iopromide |
11.1.5.Ioversol |
11.1.6.Iomeprol |
11.1.7.Gadoteric Acid |
11.1.8.Gadobutrol |
11.1.9.Gadoxetic Acid |
11.1.10.Definity |
11.1.11.Optison |
11.1.12.SonoVue/Lumason |
11.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.X-Ray/CT |
11.2.2.MRI |
11.2.3.Ultrasound |
11.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.GCC Countries |
11.3.2.South Africa |
11.3.3.Rest of MEA |
12.Latin America Contrast Media Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Iohexol |
12.1.2.Iopamidol |
12.1.3.Iodixanol |
12.1.4.Iopromide |
12.1.5.Ioversol |
12.1.6.Iomeprol |
12.1.7.Gadoteric Acid |
12.1.8.Gadobutrol |
12.1.9.Gadoxetic Acid |
12.1.10.Definity |
12.1.11.Optison |
12.1.12.SonoVue/Lumason |
12.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.X-Ray/CT |
12.2.2.MRI |
12.2.3.Ultrasound |
12.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Brazil |
12.3.2.Mexico |
12.3.3.Rest of LA |
13. Competition Landscape |
13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
13.2.1.Jodas Expoim Pvt. Ltd. |
13.2.2.GE HealthCare |
13.2.3.Unijules Life Sciences Ltd. |
13.2.4.JB Pharma |
13.2.5.Bracco |
13.2.6.Lantheus |
13.2.7.Sanochemia Pharmazeutika GmbH |
13.2.8.TAEJOON Pharmaceutical Co., Ltd. |
13.2.9.Guerbet |
13.2.10.Bayer AG |
13.2.11.Spago Nanomedical AB |
13.2.12.Biotech Limited |
13.2.13.Fuji Pharma Co., Ltd |
13.2.14.Trivitron Healthcare |
13.2.15.Subhra Pharma |
13.2.16.Beijing Beilu Pharmaceuticals Co. Ltd. |
13.2.17.Jiangsu Hengrui Pharmaceutical Co., Ltd. |
14. Research Methodology |
15. Appendix and Abbreviations |
Key Market Players